 Bobby Boyanton Jr
Concepts (197)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcal Infections | 5 | 2022 | 58 | 2.590 |
Why?
| | Molecular Diagnostic Techniques | 6 | 2019 | 40 | 2.280 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2019 | 206 | 1.670 |
Why?
| | Respiratory Tract Infections | 3 | 2024 | 86 | 1.510 |
Why?
| | Antigens, Protozoan | 2 | 2017 | 10 | 1.230 |
Why?
| | Malaria, Falciparum | 2 | 2017 | 12 | 1.230 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2020 | 75 | 1.200 |
Why?
| | Streptococcus agalactiae | 3 | 2020 | 13 | 1.160 |
Why?
| | Bacteriological Techniques | 4 | 2015 | 38 | 1.140 |
Why?
| | Diagnostic Tests, Routine | 2 | 2017 | 31 | 1.060 |
Why?
| | Coinfection | 1 | 2024 | 36 | 0.950 |
Why?
| | Pharyngitis | 1 | 2022 | 17 | 0.890 |
Why?
| | Mycoplasma pneumoniae | 2 | 2024 | 5 | 0.870 |
Why?
| | Infection Control | 1 | 2022 | 58 | 0.810 |
Why?
| | Pandemics | 2 | 2024 | 594 | 0.750 |
Why?
| | Carrier State | 1 | 2019 | 12 | 0.690 |
Why?
| | Child, Preschool | 11 | 2024 | 4158 | 0.680 |
Why?
| | Staphylococcal Infections | 1 | 2022 | 302 | 0.650 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2017 | 2 | 0.620 |
Why?
| | BK Virus | 1 | 2017 | 4 | 0.620 |
Why?
| | Polyomavirus Infections | 1 | 2017 | 11 | 0.620 |
Why?
| | Tumor Virus Infections | 1 | 2017 | 43 | 0.610 |
Why?
| | Travel | 1 | 2017 | 30 | 0.610 |
Why?
| | Transplants | 1 | 2017 | 18 | 0.600 |
Why?
| | Sensitivity and Specificity | 7 | 2019 | 922 | 0.590 |
Why?
| | Vagina | 2 | 2019 | 47 | 0.580 |
Why?
| | Pasteurella multocida | 1 | 2015 | 1 | 0.550 |
Why?
| | Pasteurella Infections | 1 | 2015 | 2 | 0.550 |
Why?
| | Molecular Typing | 1 | 2015 | 10 | 0.550 |
Why?
| | Cat Diseases | 1 | 2015 | 4 | 0.550 |
Why?
| | Meningitis, Bacterial | 1 | 2015 | 9 | 0.550 |
Why?
| | Streptococcus | 1 | 2015 | 15 | 0.550 |
Why?
| | Infant | 9 | 2022 | 3829 | 0.540 |
Why?
| | Child | 12 | 2024 | 7368 | 0.540 |
Why?
| | Zoonoses | 1 | 2015 | 18 | 0.540 |
Why?
| | Encephalitis, Herpes Simplex | 1 | 2014 | 2 | 0.500 |
Why?
| | Simplexvirus | 1 | 2014 | 12 | 0.500 |
Why?
| | Humans | 29 | 2024 | 54391 | 0.500 |
Why?
| | Herpesvirus 2, Human | 1 | 2013 | 5 | 0.480 |
Why?
| | Clostridium Infections | 2 | 2011 | 62 | 0.480 |
Why?
| | Temporal Lobe | 1 | 2014 | 75 | 0.480 |
Why?
| | Virology | 1 | 2013 | 9 | 0.480 |
Why?
| | Aphasia | 1 | 2014 | 28 | 0.480 |
Why?
| | Herpesvirus 1, Human | 1 | 2013 | 15 | 0.480 |
Why?
| | Herpes Simplex | 1 | 2013 | 24 | 0.470 |
Why?
| | Chromatography, Affinity | 1 | 2013 | 50 | 0.470 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2013 | 33 | 0.470 |
Why?
| | Gels | 1 | 2013 | 19 | 0.470 |
Why?
| | Pseudomonas Infections | 1 | 2013 | 54 | 0.450 |
Why?
| | Pseudomonas aeruginosa | 1 | 2013 | 86 | 0.450 |
Why?
| | Disease Outbreaks | 1 | 2013 | 124 | 0.430 |
Why?
| | Arkansas | 3 | 2024 | 2100 | 0.430 |
Why?
| | Adolescent | 10 | 2022 | 6900 | 0.430 |
Why?
| | Influenza, Human | 1 | 2013 | 120 | 0.420 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2011 | 11 | 0.420 |
Why?
| | Antigens, Bacterial | 1 | 2011 | 63 | 0.410 |
Why?
| | Polymerase Chain Reaction | 4 | 2015 | 531 | 0.410 |
Why?
| | Immunoenzyme Techniques | 1 | 2011 | 166 | 0.410 |
Why?
| | Bacterial Toxins | 1 | 2011 | 61 | 0.410 |
Why?
| | Adult | 11 | 2022 | 14207 | 0.400 |
Why?
| | Sequence Analysis, DNA | 2 | 2008 | 274 | 0.370 |
Why?
| | Young Adult | 7 | 2022 | 4318 | 0.370 |
Why?
| | Female | 14 | 2022 | 28471 | 0.370 |
Why?
| | Candida | 2 | 2014 | 67 | 0.340 |
Why?
| | Mass Screening | 1 | 2012 | 370 | 0.330 |
Why?
| | DNA, Fungal | 1 | 2008 | 42 | 0.320 |
Why?
| | Nervous System Neoplasms | 1 | 2007 | 4 | 0.310 |
Why?
| | Nerve Sheath Neoplasms | 1 | 2007 | 23 | 0.310 |
Why?
| | Candidiasis | 1 | 2008 | 122 | 0.300 |
Why?
| | Diagnosis, Differential | 4 | 2017 | 1141 | 0.280 |
Why?
| | Rib Fractures | 1 | 2006 | 3 | 0.280 |
Why?
| | Male | 11 | 2022 | 27347 | 0.280 |
Why?
| | Myelolipoma | 1 | 2006 | 10 | 0.280 |
Why?
| | Postoperative Complications | 1 | 2013 | 1035 | 0.280 |
Why?
| | Burkholderia gladioli | 1 | 2005 | 2 | 0.270 |
Why?
| | Granulomatous Disease, Chronic | 1 | 2005 | 3 | 0.270 |
Why?
| | Burkholderia Infections | 1 | 2005 | 6 | 0.270 |
Why?
| | Rectum | 2 | 2019 | 52 | 0.270 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2006 | 54 | 0.270 |
Why?
| | Peutz-Jeghers Syndrome | 1 | 2004 | 2 | 0.250 |
Why?
| | Middle Aged | 7 | 2017 | 13082 | 0.250 |
Why?
| | Osteomyelitis | 1 | 2005 | 124 | 0.240 |
Why?
| | Infant, Newborn | 4 | 2019 | 2923 | 0.240 |
Why?
| | Abdominal Pain | 1 | 2004 | 84 | 0.230 |
Why?
| | Streptococcus pyogenes | 1 | 2022 | 18 | 0.220 |
Why?
| | Blood Specimen Collection | 1 | 2002 | 39 | 0.220 |
Why?
| | Seroepidemiologic Studies | 1 | 2022 | 50 | 0.220 |
Why?
| | Quarantine | 1 | 2022 | 16 | 0.210 |
Why?
| | Antibodies, Viral | 1 | 2022 | 124 | 0.210 |
Why?
| | Aged, 80 and over | 3 | 2015 | 3431 | 0.200 |
Why?
| | Aged | 5 | 2017 | 10060 | 0.200 |
Why?
| | Bordetella | 1 | 2020 | 1 | 0.200 |
Why?
| | Bordetella Infections | 1 | 2020 | 1 | 0.200 |
Why?
| | Bordetella parapertussis | 1 | 2020 | 1 | 0.200 |
Why?
| | Air Microbiology | 1 | 2020 | 12 | 0.190 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 88 | 0.190 |
Why?
| | Whooping Cough | 1 | 2020 | 15 | 0.190 |
Why?
| | Adenoidectomy | 1 | 2020 | 34 | 0.190 |
Why?
| | Feces | 2 | 2011 | 137 | 0.190 |
Why?
| | Pregnancy | 3 | 2020 | 2639 | 0.190 |
Why?
| | Tonsillectomy | 1 | 2020 | 49 | 0.190 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 52 | 0.190 |
Why?
| | Prospective Studies | 4 | 2020 | 2606 | 0.180 |
Why?
| | Surgical Wound Infection | 1 | 2020 | 126 | 0.180 |
Why?
| | Asia, Southeastern | 1 | 2017 | 11 | 0.160 |
Why?
| | Plasmodium falciparum | 1 | 2017 | 18 | 0.150 |
Why?
| | False Positive Reactions | 1 | 2017 | 68 | 0.150 |
Why?
| | Viral Load | 1 | 2017 | 86 | 0.150 |
Why?
| | Staining and Labeling | 1 | 2017 | 106 | 0.150 |
Why?
| | DNA, Viral | 1 | 2017 | 143 | 0.140 |
Why?
| | Feasibility Studies | 1 | 2017 | 398 | 0.140 |
Why?
| | DNA Fingerprinting | 1 | 2015 | 38 | 0.140 |
Why?
| | Molecular Epidemiology | 1 | 2015 | 36 | 0.140 |
Why?
| | Cats | 1 | 2015 | 52 | 0.140 |
Why?
| | Family Characteristics | 1 | 2015 | 58 | 0.130 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2015 | 92 | 0.130 |
Why?
| | Kidney Transplantation | 1 | 2017 | 189 | 0.130 |
Why?
| | Vaginal Discharge | 1 | 2014 | 1 | 0.130 |
Why?
| | Trichomonas Vaginitis | 1 | 2014 | 3 | 0.130 |
Why?
| | Candidiasis, Vulvovaginal | 1 | 2014 | 3 | 0.130 |
Why?
| | Microbiological Techniques | 1 | 2014 | 11 | 0.130 |
Why?
| | Vaginosis, Bacterial | 1 | 2014 | 14 | 0.130 |
Why?
| | Biopsy | 1 | 2017 | 692 | 0.130 |
Why?
| | Acyclovir | 1 | 2014 | 10 | 0.130 |
Why?
| | Cerebrospinal Fluid | 1 | 2014 | 36 | 0.120 |
Why?
| | Spinal Puncture | 1 | 2014 | 20 | 0.120 |
Why?
| | Transition Temperature | 1 | 2013 | 6 | 0.120 |
Why?
| | Kidney Diseases | 1 | 2017 | 293 | 0.120 |
Why?
| | Fever | 1 | 2014 | 129 | 0.120 |
Why?
| | Time Factors | 2 | 2015 | 3210 | 0.120 |
Why?
| | Magnetic Resonance Imaging | 2 | 2014 | 1616 | 0.110 |
Why?
| | Intraoperative Care | 1 | 2013 | 58 | 0.110 |
Why?
| | Operative Time | 1 | 2013 | 76 | 0.110 |
Why?
| | Heart Valve Diseases | 1 | 2013 | 42 | 0.110 |
Why?
| | Polymorphism, Genetic | 1 | 2013 | 193 | 0.110 |
Why?
| | Antiviral Agents | 1 | 2014 | 188 | 0.110 |
Why?
| | Echocardiography, Transesophageal | 1 | 2013 | 73 | 0.110 |
Why?
| | Colonic Neoplasms | 1 | 2014 | 164 | 0.110 |
Why?
| | Predictive Value of Tests | 2 | 2014 | 1045 | 0.110 |
Why?
| | Kidney | 1 | 2017 | 822 | 0.100 |
Why?
| | United States | 3 | 2020 | 5208 | 0.100 |
Why?
| | Nasopharynx | 2 | 2020 | 32 | 0.100 |
Why?
| | Length of Stay | 1 | 2013 | 683 | 0.090 |
Why?
| | Cross Infection | 1 | 2011 | 109 | 0.090 |
Why?
| | Retrospective Studies | 2 | 2020 | 6459 | 0.080 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2007 | 116 | 0.080 |
Why?
| | Mycological Typing Techniques | 1 | 2008 | 3 | 0.080 |
Why?
| | Mucin-1 | 1 | 2007 | 3 | 0.080 |
Why?
| | Ulnar Nerve | 1 | 2007 | 4 | 0.080 |
Why?
| | Leprosy | 1 | 2007 | 6 | 0.080 |
Why?
| | Tongue | 1 | 2007 | 41 | 0.080 |
Why?
| | Base Sequence | 1 | 2008 | 719 | 0.070 |
Why?
| | Bacterial Infections | 1 | 2007 | 105 | 0.070 |
Why?
| | Genotype | 1 | 2008 | 600 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2008 | 980 | 0.070 |
Why?
| | Ossification, Heterotopic | 1 | 2006 | 8 | 0.070 |
Why?
| | Adrenal Glands | 1 | 2006 | 38 | 0.070 |
Why?
| | Bacteria | 1 | 2007 | 258 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2008 | 552 | 0.060 |
Why?
| | Adipocytes | 1 | 2006 | 128 | 0.060 |
Why?
| | Phenotype | 1 | 2008 | 819 | 0.060 |
Why?
| | Jejunal Diseases | 1 | 2004 | 3 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2007 | 720 | 0.060 |
Why?
| | Intussusception | 1 | 2004 | 8 | 0.060 |
Why?
| | Anastomosis, Surgical | 1 | 2004 | 72 | 0.060 |
Why?
| | Jejunum | 1 | 2004 | 56 | 0.060 |
Why?
| | Necrosis | 1 | 2004 | 208 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2007 | 1097 | 0.060 |
Why?
| | Ischemia | 1 | 2004 | 177 | 0.060 |
Why?
| | Blood Cells | 1 | 2002 | 58 | 0.050 |
Why?
| | Plasma | 1 | 2002 | 52 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2005 | 1082 | 0.050 |
Why?
| | Bordetella pertussis | 1 | 2020 | 3 | 0.050 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2020 | 16 | 0.050 |
Why?
| | Alcoholism | 1 | 2004 | 249 | 0.050 |
Why?
| | Risk Assessment | 1 | 2005 | 1362 | 0.050 |
Why?
| | Antibiotic Prophylaxis | 1 | 2020 | 67 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2006 | 1222 | 0.050 |
Why?
| | Follow-Up Studies | 1 | 2005 | 2390 | 0.040 |
Why?
| | Risk | 1 | 2020 | 343 | 0.040 |
Why?
| | Animals | 1 | 2015 | 14409 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2005 | 825 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2020 | 743 | 0.040 |
Why?
| | Cohort Studies | 1 | 2020 | 1546 | 0.030 |
Why?
| | Gardnerella vaginalis | 1 | 2014 | 2 | 0.030 |
Why?
| | Trichomonas vaginalis | 1 | 2014 | 5 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2005 | 5612 | 0.030 |
Why?
| | Point-of-Care Systems | 1 | 2014 | 71 | 0.030 |
Why?
| | Risk Factors | 1 | 2020 | 3937 | 0.030 |
Why?
| | DNA, Ribosomal | 1 | 2007 | 28 | 0.020 |
Why?
| | PubMed | 1 | 2007 | 10 | 0.020 |
Why?
| | Granuloma | 1 | 2007 | 45 | 0.020 |
Why?
| | Dermatitis | 1 | 2007 | 42 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2007 | 172 | 0.020 |
Why?
| | Sarcoidosis | 1 | 2007 | 44 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2007 | 270 | 0.020 |
Why?
| | Prevalence | 1 | 2007 | 1025 | 0.010 |
Why?
|
|
Boyanton Jr's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|